Summary My cobacterium leprae eell wall-associated eomponents are found in large amounts in the tissues of leprosy patients, partieularly those at the lepromatous pole. Among these moleeules, the phenolie glyeolipid-I (PGL-I), unique to M. leprae, has been involved in the seleetive anergy observed in the lepromatous patients. Armadillo-derived M. leprae retains only a small proportion of the total PGL-I found in infeeted tissues. Therefore, the addition of PGL-I to M. leprae in vitro is important for a better understanding of M. leprae effeets in vivo. We have studied the influenee of PGL-I on TNF produetion by normal human peripheral blood mononuc1ear eells (PBMC) and by a human monoeytie leukaemia eell line (THP-l) following stimula tion with killed M. leprae. PGL-I alone did not induee TNF seeretion by PBMC, but when assoeiated with a sub-optimal dose of armadillo-derived M. leprae inereased the release of this eytokine. ln agreement with these results, M. leprae-exposed THP-1 eells did not seerete deteetable leveIs of TNF unless PGL-I was simultaneously added to the eulture. This inerease in TNF produetion suggests that PGL-I plays a role in the induetion of TNF during the natural infeetion. ln addition, the modulatory effeet of PGL-I on TNF release by THP-l eells reinforees that monoeytes are one of the possible targets of this moleeule.
unique to M. leprae, 3 . 4 has been implicated in the selective anergy observed in lepromatous leprosy patients. 5 ln vitro findings indicate that PGL-I interferes with the cellular immune response at the leveI of both macrophage function (measured by the release of inflammatory cytokines such as TNF and by generation of oxygen radicals) and lymphocyte prolifer ation. 5 -9 Moreover, PGL-I fixes selectively the complement component C3 and thus helps to mediate M. leprae phagocytosis via complement receptors on the surface of mononuc1ear phagocytes. l O , l 1 ln mycobacterial infections TNF is involved in both host protective response and disease pathology. 1 2 Whole mycobacteria andJor cell wall associated components stimulate TNF release by murine macrophages and by mononuc1ear ce1ls from normal individuaIs or leprosy patients in vitro. 1 3 -16 However, little is known of the factors which trigger TNF release during the course of the disease. We have studied the influence of PGL-I on TNF production by normal human peripheral blood mononuc1ear cells (PBMC) following stimulation with M. leprae. Alternatively, THP-l cells, a human myelomonocytic cell line that lately has been extensively employed in studies of mechanisms of maturationldifferentiation from monocytes to macrophages, 1 7 were used as host cells. M. leprae PGL-I is an extracellular product forming a loose capsule around the bacillus which is partially lost during the purification procedure from infected tissues. 4 It therefore seems necessary to add PGL-I to the armadillo-derived M. leprae for a better understanding of M. leprae effects in vivo. ln addition, this approach helps to c1arify PGL-I contribution to these effects. Our results suggest that PGL-I acts as a co-signal for TNF production by M. leprae-exposed mononuc1ear ce1ls, but has no detectable effect when added alone to unstimulated cultures. The possible relevance of these in vitro results to the leprosy pathogenesis is discussed.
Materiais and methods

SOURCE OF REAGENTS
RPMI 1640 medium, penicillinlstreptomycin, L-glutarnine were obtained from Gibco BRL (Gaithersburg, MD, USA), heat-inactivated fetal calf serum was purchased from Fazenda Pigue (Rio de Janeiro, RJ, Brazil), FicoU was obtained from Sigma Chernical Coo (St Louis, MO, USA).
PBMC CULTURE AND STIMULATION
Peripheral blood mononuc1ear cells (PBMC) were isolated from six healthy individuaIs, five of them living in Rio de Janeiro and one being a visitor from the UK. PBMC were separated by Ficoll-Hypaque density gradient from sterile heparinized blood, washed three times in PB S and resuspended in RPMI-I640 medium supplemented with 5% AB human serum, 100 lU/mI penicillin, 100 ILg/mI streptomycin, 10 mM Hepes and 2 mM L-glutarnine. Two culture conditions were used, as follows: (i) 3 x 10 5 cells in 0·2 mI mediurn/well were dispensed in 96-well flat-bottomed rnicrotitre plates or (ii) 2 x 10 6 cells in 1 mI mediurn/well were dispensed in 24-well rnicrotitre plates and cultured with or without stimulants (as below) for 24 h at 37°C in a hurnidified atmosphere of 5% CO 2 .
THP-l CULTURE ANO STIMULA TION
Cells from a human myelomonocytic cell line, THP-1 (American Type Culture Collection, Rockville, MD, USA), were maintained in suspension cultures in RPMI medium supplemented with 10% heat-inactivated fetal calf serum, 100 lU/mI penicillin, 100 lLg/mI streptomycin, 10 mM Hepes and 2 mM glutarnine, at 37°C in a hurnidified atmosphere of 5% CO 2 and used between three and 14 passages. For the experiments, 2 x 10 5 cells in 1 mI of the sarne medium/well were dispensed in 24-well rnicrotitre plates and cultured with or without stimulants up to 48 h at 37°C in a hurnidified atmosphere of 5% CO 2 . After the incubation period, the culture supernatants of PBMC or THP-1 cells were collected for TNF quantitation.
STIMULANTS
Irradiated armadillo-derived M. leprae and PGL-I were obtained as described. 4 Evaluation of PGL-I for the presence of Gram-negative bacterial endotoxin (LPS) was done with the amebocyte assay (QCL-1000 kit, BioWhittaker, Inc., Walkersville, MD, USA). Two lots of PGL-I obtained between 1994 and 1997 contained <0.5 pg of LPS per ILg of PGL-1 per batch. Because of its insolubility in aqueous medi um, PGL-I was presented to PBMC or THP-1 cells immobilised onto the rnicroplate well. Briefty, PGL-I stock solutions in ethanol were added to culture wells and dried under sterile conditions before cell addition. The sarne concentration of ethanol was added to control wells, although ethanol alone had no detectable effect in our conditions. PGL-I final concentration in cultures was 1 or 25 ILg/mI; M. leprae was presented to PBMC or THP-1 ce1ls over a concentration range of 1.25-40 ILg/mI (approximate1y 3 x 10 6 _10 8 organisms/ml).
TNF DETECTION
Supematants were adequately diluted in PB S and assayed in duplicates. TNF leveIs were deterrnined by ELISA using specific pairs of monoc1onal antibodies and human recombinant TNF as standard, according to the manufacturer recommendations (Pharrni ngen, San Diego, CA, USA). The lirnit of sensitivity was 250 pg/mI of recombinant TNF.
STATISTICAL ANALYSIS
The Friedman test and Wi1coxon signed ranks test were performed with data shown in 
Results
EFFECT OF POL·I ON TNF PROOUCTION BY PBMC STIMULATEO WITH M. LEPRA E
We compared TNF leveIs produced by PBMC simultaneously treated with PGL-I and M. leprae to the leveIs produced by mononuc1ear cells exposed to M. leprae alone (Figure 1 ). Optimal incubation time for TNF secretion was initially deterrnined by stimulating the cells with M. leprae for 4, 12, 24 and 48 h, with a peak leveI observed at 12-24 h (not shown). PBMC did not re1ease detectable arnounts of TNF into cell medium when cultivated for the sarne periods of time in the presence of PGL-I or medium alone. The stimulation of PBMC cultures with M. leprae induced TNF release by ce1ls of all tested subj ects as previously shown by others. 1 5 However, the profile of TNF release in response to M. leprae exposure varied substantialIy among the different individuaIs over the eoneentration range used. ln the presenee of the M. leprae dose that indueed the lowest amount of TNF for eaeh subjeet (sub optimal M. leprae dose), PGL-I enhaneed TNF leveIs in alI subjeets (Figure 1, P < 0·009) . When other M. leprae doses were used, PGL-I had eomplex effeets, either inereasing or deereasing the TNF release in the sarne individual (not shown). Both PGL-I doses (1 and 25 j.tglrnl) indueed eomparable leveIs of TNF when added to M. leprae-stimulated PBMC (P < 0·65). Subjeets a, b, e, d and f were previously exposed to M. leprae, differently from subj eet e, who lives in a non-endemie area. Subjeet e-derived PBMC, eompared to the other subjeets, produeed lower leveIs of TNFa in response to alI tested doses of M. leprae.
Removing the values referring to this subjeet from the statistieal analysis, the differenee in TNF produetion between PBMC ehalIenged with M. leprae and PBMC ehalIenged with M.l eprae and PGL-I is stilI signifieant (P < 0·023).
THP-1 eelIs are funetionally very similar to peripheral blood monoeytes. 1 8 , 19 We thus tested the effeet of added PGL-I in M. leprae indueed TNF. PGL-I qualitatively modified the TNF response pattem of THP-1 eells to M. leprae. Differently from PBMC (Figure 1 ), THP-1 eelIs did not seerete measurable leveIs of TNF when stimulated with M. leprae unless PGL-I was added to the eulture. TNF seeretion was deteeted after 48 h of simultaneous exposure to PGL-I and M. leprae (Figure 2 ), but not at early time points. THP-1 eelIs also showed similar response kineties to PMA, fo lIowed by morphological eriteria 19 and measurement of TNF leveIs in eulture supematants (M. M. Oliveira, R. Charlab and M. C. V. Pessolani, submitted). As observed before, PGL-I alone did not stimulate the produetion of measurable leveIs of TNF (Figure 2) . �.
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PGL-I, 1 no PGL-I PGL-I (10r 25) or media + M. leprae + M. leprae + M. leprae without M. leprae Figure 1 . Effect of PGL-I on TNF production by M. leprae-stimulated PBMC. PBMC of six healthy subjects (a, b, c, d, e,f; 2x 10 6 /ml) were incubated witb a sub-optimal dose of M. leprae for TNF release (over a range of 1.25-40 p.g1 mi), PGL-I immobilized in tbe culture microplates (1 and 25 p.g/mI) or botb for 24 h. TNF concentration in culture supernatants was determined by ELISA. PBMC cultivated witbout M. leprae in tbe presence of PGL-I or medium alone secreted undetectable leveis of TNF. M. leprae doses which induced tbe lowest amount of TNFa for each subject were, respectively: a 20 p.g1m1; b 2 p.g1m1; c 20 p.g1m1; d 5 p.g/mI; e 10 p.g1m1;f 40 p.g1m1. Cultures exposed to PGL-I and M. leprae were statistically different from cultures exposed to M. leprae alone (P < 0,009). TNF values of cultures exposed to M. leprae and 1 /lglrnl of PGL-I were not statistically different from tbe values of cultures exposed to M. leprae and 25 p.glmI of PGL-I (P < 0·65). 
Discussion
It is now well aeeepted that PGL-I is produeed in large amounts during M. leprae infeetion, being found in serum, urine and in the skin lesions of leprosy patients. 1,2,20 This feature allied to its eapaeity to affeet both lymphoeyte and maerophage funetions (reviewed by Brennan et a!. 3 ) and to elieit a strong antibody response in leprosy patients, zl points to an involvement of PGL-I in the pathogenesis of M. leprae. To examine whether the addition of PGL-1 affeets M. leprae aetion in vitro, we evaIuated TNF produetion by PBMC of normal individuaIs or by THP-l monoeytie eells exposed to M. leprae in the presenee or absenee of free PGL-1. ln this study, PGL-I alone did not induee TNF seeretion by PBMC of healthy individuaIs or by THP-l eells, but when assoeiated with M. leprae modulated the release of this eytokine. PGL-I inereased TNF produetion by PBMC stimulated with sub-optimal doses of M. leprae. However, positive or negative modulatory effeets of PGL-I were observed in the different individuaIs and in the same individual when other eoneentrations of M. leprae were used. These variations may be related to differenees in the genetie baekground (e.g. high or low type TNF produeers), funetional status of the PBMC donors, heterogeneity of the PBMC population and of the monoeyte subset by itself. It is also worthy to mention at this point that we have not adjusted the number of PBMC to tum equal the eounts of monoeytes to all individuaIs tested. This should eertainly be done if we were working with purified monoeytes and not with sueh a heterogeneous population of eells as PBMC, in whieh other eell types sueh as NK and T -eells eould also eontribute to TNF seeretion. Instead, we preferred to use a wide range of M. leprae doses for eaeh individual, determining a sub-optimal dose for eaeh one and then use this dose to investigate the effeet of PGL-1.
The inerease in TNF produetion observed when PGL-I was added to M. leprae-stimulated eultures suggests that this eomponent plays a role in TNF induetion during the natural infection. This observation was reinforced when THP-I cells were co-cultured with PGL-I and M. leprae. We have previously shown that M. bovis BCG but not M. leprae induced TNFa secretion in THP-I cells, while both mycobacteria stimulated the release of this cytokine by human PBMC (M. M. Oliveira, R. Charlab and M. C. V. Pessolani, submitted). This result emphasises the potential of THP-I cells as a model to explore the role of PGL-1 on TNF secretion. ln the present work, the addition of PGL-I was essential for detection of TNF in the culture supematants. M. leprae-exposed THP-I cells only secreted detectable leveIs of TNF when PGL-I was simultaneously present in the culture.
The modulatory effect of PGL-I on TNF production by THP-I monocytic cells suggests that monocytes are one of the possible targets of this molecule. ln this respect it has been shown that PGL-I incorporated in liposomes inhibited the secretion of TNF, IL-I and IL-6 by LPS-stimulated peripheral blood-derived monocytes from healthy individuals, 22 but, in agreement with our results, had no effect when added alone to non-stimulated controls. The authors used LPS at 10 j.tg/rnl. However, we verified that, at lower LPS doses, PGL-I, either incorporated in liposomes or immobilized in culture microplates was also able to incre ase TNF production by PBMC of normal subjects. It · is worth to mention that undifferentiated THP-I cells did not secrete detectable leveIs of TNFa in response to LPS from 100 ng to 10 j.tg/rnl, a behaviour already observed by others.
23 The production of TNF by LPS-stimulated THP-I cells was not detected even when PGL-I was simultaneously added to the cultures (R. Charlab, unpublished results). ln this study, we showed that PGL-I did not induce the secretion of TNF by PBMC of healthy individuaIs, but positively or negatively modulated the release of this cytokine induced by M. leprae. ln this context, one can speculate that PGL-I may have different roles on the pathogenicity along the c1inical spectrum of leprosy and in reactional and non reactional stages of the disease. Depending on the infection status, PGL-I may either increase or suppress the infiammatory response in the infected tissue, contributing, respectively, to sustain a low specific response to M. leprae or to enhance tissue damage.
